This report has been updated. Click here to view latest edition.
If you have previously purchased the archived report below then please use the download links on the right to download the files.
1. | EXECUTIVE SUMMARY |
1.1. | Executive introduction: Electronic skin patches |
1.2. | Application overview |
1.3. | Applications, market sizes and outlook |
1.4. | CGM leads the way |
1.5. | Insulin pumps and patch pumps |
1.6. | Diabetes management: full historic data and forecast |
1.7. | Monitoring the heart via skin patches |
1.8. | Players and product types in cardiac monitoring |
1.9. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
1.10. | Cardiac monitoring skin patches: Market forecasts |
1.11. | Skin patches patient monitoring: Historic data: 2010-2019 |
1.12. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
1.13. | Skin patch temperature sensing: Use cases across 12 case studies |
1.14. | Key conclusions: Temperature sensing skin patches |
1.15. | Electrical stimulation product types |
1.16. | Skin patches in bioelectronic medicine |
1.17. | Electrical stimulation via skin patches: Market data (2010-2019) |
1.18. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
1.19. | Introduction - Iontophoresis |
1.20. | Iontophoresis via skin patches: Market data (2010-2019) |
1.21. | Iontophoresis via skin patches: Market forecast (2020-2030) |
1.22. | Key conclusions: Iontophoresis |
1.23. | Examples of players from case studies |
2. | INTRODUCTION |
2.1.1. | The case for skin patches: Augmenting the human body |
2.1.2. | The case for skin patches: Improving device form factor |
2.1.3. | Definitions and exclusions |
2.1.4. | History of skin patches |
2.1.5. | Applications, market sizes and outlook |
2.1.6. | Reimbursement drives commercial business models |
2.1.7. | Patents: Total active patents by assignee |
2.1.8. | Patents over time |
2.1.9. | Patents: Active and strong patents by assignee |
2.1.10. | Context: Wearables hype |
2.1.11. | Glossary |
2.2. | Application overview |
2.2.1. | Skin patches competing with established products |
2.2.2. | New market creation around skin patches |
2.2.3. | Section contents |
3. | DIABETES MANAGEMENT VIA SKIN PATCHES |
3.1.1. | Background: Diabetes in numbers |
3.1.2. | Background: Diabetes on the rise |
3.1.3. | Background: The cost of diabetes |
3.1.4. | Diabetes management process |
3.1.5. | Diabetes management device roadmap: Summary |
3.1.6. | Diabetes management device roadmap: Sensors |
3.1.7. | The case for continuous glucose monitoring (CGM) |
3.1.8. | Anatomy of a typical CGM device |
3.1.9. | Anatomy of a CGM sensor |
3.1.10. | CGM is deployed via skin patches |
3.1.11. | Non-invasive glucose monitoring? |
3.1.12. | Opinions against non-invasive glucose monitoring |
3.2. | Key players in continuous glucose monitoring (CGM) |
3.2.1. | CGM: Overview of key players |
3.2.2. | Abbott Laboratories |
3.2.3. | Abbott: FreeStyle Libre |
3.2.4. | Abbott: SMBG vs CGM comparison |
3.2.5. | Dexcom |
3.2.6. | Medtronic |
3.2.7. | Medtronic: Patents in CGM |
3.2.8. | Roche |
3.2.9. | Roche: Patents in CGM |
3.2.10. | Senseonics |
3.3. | Other players |
3.3.1. | Ascensia & POCTech |
3.3.2. | AgaMatrix & WaveForm Technologies |
3.3.3. | PKVitality |
3.3.4. | Sano |
3.3.5. | DiabeLoop |
3.3.6. | Verily / Google: Contact lenses |
3.4. | Insulin delivery |
3.4.1. | Diabetes management device roadmap: Insulin delivery |
3.4.2. | Insulin pumps: Introduction |
3.4.3. | Insulin pumps currently available |
3.4.4. | Insulin pump breakdown |
3.4.5. | Insulin patch pumps |
3.4.6. | Example: Progress from Medtronic |
3.4.7. | Outlook for insulin pumps |
3.5. | Linking insulin pumps and CGM: Towards an artificial pancreas |
3.5.1. | Today: Hybrid closed loop systems |
3.5.2. | Example: Progress from Medtronic |
3.5.3. | The objective: Closing the feedback loop |
3.5.4. | Examples and partnerships |
3.6. | Market data: Historic & forecasts |
3.6.1. | A shifting focus in diabetes management - Historic data: 2010-2019 |
3.6.2. | Test strip business in decline |
3.6.3. | The growth of CGM accelerates |
3.6.4. | Diabetes management: full historic data and forecast |
3.6.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
4. | CARDIOVASCULAR MONITORING SKIN PATCHES |
4.1.1. | Introduction - Cardiovascular monitoring via wearable devices |
4.1.2. | Introduction - Measuring biopotential |
4.1.3. | Technology overview - the circuitry for measuring biopotential |
4.1.4. | Introduction - Electrocardiography (ECG, or EKG) |
4.1.5. | Devices for cardiac monitoring |
4.1.6. | Cardiac monitoring device types - skin patches |
4.1.7. | Companies and product types |
4.1.8. | Technology overview - electrode properties |
4.1.9. | Disposable Ag/AgCl electrodes |
4.1.10. | Electrodes: Traditional approaches |
4.1.11. | Skin patches with disposable electrodes |
4.1.12. | Skin patches with integrated electrodes |
4.1.13. | Reimbursement codes for wearable cardiac monitors |
4.1.14. | 2021: New reimbursement structure in place |
4.2. | Players |
4.2.1. | Summaries and interviews with 20 industry players |
4.2.2. | BioTelemetry, Inc. |
4.2.3. | BioTelemetry: Timeline |
4.2.4. | iRhythm |
4.2.5. | ScottCare |
4.2.6. | VivaLNK |
4.2.7. | Fukuda Denshi |
4.2.8. | Fujita Medical Instruments |
4.2.9. | Bittium |
4.2.10. | Byteflies & Quad Industries |
4.2.11. | Cardiomo |
4.2.12. | Vivomi |
4.2.13. | QT Medical |
4.2.14. | SWMedical |
4.2.15. | SWMedical - CardiNova |
4.2.16. | Seers Technology |
4.2.17. | Rooti |
4.2.18. | Preventice Solutions |
4.2.19. | Sigknow |
4.2.20. | Borsam |
4.2.21. | Cortrium |
4.2.22. | Qardio |
4.2.23. | Holst Center: Skin patches |
4.2.24. | Medtronic: SEEQ MCT (discontinued) |
4.2.25. | LumiraDx / FitLinxx: Ampstrip (discontinued) |
4.3. | Competition with other form factors |
4.3.1. | Other form factors for ambulatory cardiac monitoring |
4.3.2. | Wearable vs implantable monitoring |
4.3.3. | Example: Medtronic (SEEQ & LINQ) |
4.3.4. | Comparison: Chest straps |
4.3.5. | Comparison: Apparel |
4.3.6. | Comparison: Portable devices |
4.3.7. | Comparison: Smartwatch optical HRM |
4.4. | Market data and forecasts |
4.4.1. | Market overview and forecasts |
4.4.2. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
4.4.3. | Cardiac monitoring skin patches: Market forecasts |
4.4.4. | Comparison - 2019 & 2020 report forecasts |
4.4.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
4.4.6. | Key conclusions: cardiac monitoring skin patches |
5. | GENERAL PATIENT MONITORING |
5.1.1. | Introduction |
5.2. | Wireless inpatient monitoring via skin patches |
5.2.1. | Inpatient monitoring: The case for removing the wires |
5.2.2. | Players and approaches |
5.2.3. | Sensium (Surgical Company Group) |
5.2.4. | VitalConect |
5.2.5. | Isansys Lifecare |
5.2.6. | Leaf Healthcare |
5.3. | Pregnancy monitoring with skin patches |
5.3.1. | GE Healthcare - Monica Novii |
5.4. | General outpatient monitoring with skin patches |
5.4.1. | Qualcomm Life |
5.4.2. | Qualcomm Life / Capsule Technologies |
5.4.3. | LifeSignals |
5.4.4. | Samsung |
5.4.5. | MC10 |
5.4.6. | DevInnova / Scaleo Medical |
5.4.7. | Avanix |
5.4.8. | Avanix - business model and target milestones |
5.5. | Market forecasts |
5.5.1. | Skin patches patient monitoring: Historic data: 2010-2019 |
5.5.2. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
5.5.3. | Conclusions & related areas |
6. | TEMPERATURE SENSING SKIN PATCHES |
6.1. | Introduction - Body Temperature |
6.2. | Temperature sensing technology options |
6.3. | Approaches and standards for medical temperature sensing |
6.4. | Skin patches for temperature sensing |
6.5. | Skin patch temperature sensing: Use cases across 12 case studies |
6.6. | VivaLNK |
6.7. | VivaLNK & Reckitt Benckiser |
6.8. | Blue Spark |
6.9. | Blue Spark & TempTraq® |
6.10. | Life Science Technology |
6.11. | Isansys Lifecare |
6.12. | Raiing Medical |
6.13. | Bonbouton |
6.14. | CSEM |
6.15. | Covestro |
6.16. | Chois Technology |
6.17. | Alternative options: Tympanic temperature sensing |
6.18. | Key conclusions: Temperature sensing skin patches |
7. | ELECTRICAL STIMULATION WITH SKIN PATCHES |
7.1.1. | Introduction: Types of electrical stimulation |
7.1.2. | Differentiation for electrical stimulation |
7.1.3. | Nomenclature in electrical stimulation |
7.1.4. | Electrical stimulation product types |
7.1.5. | Medical vs non-medical devices |
7.1.6. | Bioelectronic Medicine: Definition and background |
7.1.7. | Major Forms of Bioelectronic Medicine |
7.1.8. | The Evolution of Bioelectronic Medicine |
7.1.9. | Skin patches in bioelectronic medicine |
7.2. | TENS |
7.2.1. | TENS - Introduction |
7.2.2. | Innovative Health Solutions: NSS-2 Bridge |
7.2.3. | BeWellConnect: MyTens |
7.2.4. | NeuroMetrix: Quell |
7.2.5. | Theranica: Nerivio Migra |
7.3. | EMS / NMES / FES |
7.3.1. | EMS, NMES and FES |
7.3.2. | Applications of EMS / NMES |
7.3.3. | Example: Russian Stimulation |
7.3.4. | Example: Therapeutic settings and uses |
7.3.5. | Properties of the stimulation (as presented with a therapeutic focus) |
7.3.6. | First Kind Medical: geko |
7.3.7. | Example: HiDow |
7.3.8. | Hivox Biotek |
7.4. | Market data and forecasts |
7.4.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
7.4.2. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
8. | IONTOPHORESIS SKIN PATCHES: COSMETICS AND DRUG DELIVERY |
8.1.1. | Introduction - Iontophoresis |
8.2. | Cosmetics |
8.2.1. | Cosmetic skin patches |
8.2.2. | Estée Lauder |
8.2.3. | BioBliss™, Iontera, Patchology |
8.2.4. | Feeligreen (Feeligold) |
8.3. | Drug delivery |
8.3.1. | Iontophoresis for drug delivery |
8.3.2. | Drugs studied for iontophoretic delivery |
8.3.3. | Commercial activity with drug delivery patches |
8.3.4. | Feeligreen (Feelicare) |
8.3.5. | Seoul National University: Parkinson's medication via skin patches |
8.4. | Reverse iontophoresis |
8.4.1. | Example: GlucoWatch |
8.4.2. | Nemaura Medical: sugarBEAT |
8.5. | Market forecasts and conclusions |
8.5.1. | Iontophoresis via skin patches: Market data (2010-2019) |
8.5.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
8.5.3. | Key conclusions: Iontophoresis |
9. | SWEAT SENSING: SWEAT RATE AND BIOMARKERS |
9.1.1. | Introduction - Sweat sensing |
9.1.2. | Measuring sweat rate |
9.1.3. | Technology overview - measuring bioimpedance |
9.1.4. | Technology overview - Galvanic skin response (GSR) |
9.1.5. | Technology overview - humidity sensors for sweat |
9.1.6. | GE Global Research |
9.2. | Sensing biomarkers in sweat |
9.2.1. | Technology overview - chemical sensing in sweat |
9.2.2. | Sweat vs other sources of analytes |
9.2.3. | Analytes in sweat |
9.2.4. | Technology overview: Chemical sensing |
9.2.5. | Biolinq |
9.2.6. | Kenzen |
9.2.7. | Milo Sensors |
9.2.8. | Eccrine Systems |
9.2.9. | PARC / UCSD |
9.2.10. | Stanford and UC Berkeley |
9.2.11. | Xsensio |
9.2.12. | Epicore Biosystems |
9.2.13. | Key conclusions: Sweat sensing |
10. | WOUND MONITORING AND TREATMENT WITH SKIN PATCHES |
10.1. | Wound Monitoring |
10.2. | Wound Monitoring: KAUST |
10.3. | Wound Monitoring: Purdue University |
10.4. | Wound Monitoring: Tufts University |
10.5. | Wound Monitoring: Tyndall National Institute |
10.6. | Wound Monitoring: UC Berkeley |
10.7. | Wound Monitoring: UCSD |
10.8. | Wound Monitoring: VTT |
10.9. | Wound Treatment |
11. | MOTION SENSING WITH SKIN PATCHES |
11.1.1. | Introduction - Monitoring motion via skin patches |
11.1.2. | Different modes for sensing motion |
11.2. | Measuring motion with inertial measurement units |
11.2.1. | Introduction - Inertial measurement units |
11.2.2. | Measuring motion with IMUs: Examples |
11.2.3. | Value chain and examples of players |
11.2.4. | IMUs in skin patches |
11.2.5. | Measuring motion with conformal sensors |
11.2.6. | Introduction - alternatives for measuring motion |
11.2.7. | Technology overview - Resistive/piezoresistive sensing |
11.2.8. | Players and industry dynamic |
11.2.9. | Peratech |
11.2.10. | Quantum tunnelling composite: QTC® |
11.2.11. | QTC® vs. FSR™ vs. piezoresistor? |
11.2.12. | Bebop Sensors |
11.2.13. | Bainisha |
11.2.14. | Technology overview - Capacitive sensing |
11.2.15. | Parker Hannifin |
11.2.16. | Stretchsense |
11.2.17. | LEAP Technology |
11.2.18. | Technology overview - Piezoelectric sensing |
11.3. | Application examples |
11.3.1. | Applications for skin patch motion sensors |
11.3.2. | Case study - Concussion detection |
11.3.3. | X2 Biosystems |
11.3.4. | US Military head trauma patch / PARC |
11.3.5. | Key conclusions: Motion sensing |
12. | SKIN PATCHES AS A COMMUNICATION GATEWAY TO IMPLANTS |
12.1.1. | Communication with implants |
12.2. | Examples in bioelectronic medicine |
12.2.1. | Skin patches with bioelectronic medicine implants |
12.2.2. | NeuroRecovery Technologies |
12.2.3. | Stimwave: Freedom SCS |
12.2.4. | SPR Therapeutics: Sprint PNS |
12.2.5. | Bioness: StimRouter |
12.3. | Other examples |
12.3.1. | Proteus Digital Health |
12.3.2. | GraftWorx |
13. | OTHER APPLICATIONS OF SKIN PATCHES |
13.1. | Bladder volume sensing (wearable ultrasound) |
13.1.1. | Novioscan |
13.1.2. | Triple W - D Free |
13.2. | Other healthcare & medical applications |
13.2.1. | Acoustic respiration rate (Acurable, Masimo, etc.) |
13.2.2. | UV protection |
13.2.3. | MC10 & L'Oréal: Wisp |
13.2.4. | Lief Therapeutics: Stress Management |
13.3. | Others |
13.3.1. | EOG - eye tracking with skin patches |
14. | MARKET FORECASTS |
14.1.1. | Forecast details and assumptions |
14.2. | Diabetes management forecasts |
14.2.1. | A shifting focus in diabetes management - Historic data: 2010-2019 |
14.2.2. | Test strip business in decline |
14.2.3. | The growth of CGM accelerates |
14.2.4. | Diabetes management: full historic data and forecast |
14.2.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
14.3. | Cardiovascular monitoring forecasts |
14.3.1. | Market overview and forecasts |
14.3.2. | Cardiac monitoring skin patches: Historic data: 2010-2019 |
14.3.3. | Cardiac monitoring skin patches: Market forecasts: 2020-2030 |
14.3.4. | Comparison - 2019 & 2020 report forecasts |
14.3.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
14.4. | Patient monitoring forecasts |
14.4.1. | Skin patches patient monitoring: Historic data: 2010-2019 |
14.4.2. | Skin patch patient monitoring: Market forecasts: 2020-2030 |
14.5. | Electrical stimulation forecasts |
14.5.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
14.5.2. | Electrical stimulation via skin patches: Market forecast (2020-2030) |
14.6. | Temperature sensing forecasts |
14.6.1. | Key conclusions: Temperature sensing skin patches |
14.7. | Iontophoresis forecasts |
14.7.1. | Iontophoresis via skin patches: Market data (2010-2019) |
14.7.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
14.8. | Other skin patch forecasts |
14.8.1. | Other skin patches |
15. | LIST OF 121 ELECTRONIC SKIN PATCH PRODUCTS AND PLAYERS |
15.1. | List of company profiles and interviews |
スライド | 405 |
---|---|
フォーキャスト | 2030 |